{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:11:47Z","timestamp":1790673107999,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.ijantimicag.2018.12.004","type":"journal-article","created":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T03:36:41Z","timestamp":1545363401000},"page":"318-324","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Analysis of mutational patterns in quinolone resistance-determining regions of GyrA and ParC of clinical isolates"],"prefix":"10.1016","volume":"53","author":[{"given":"Lev","family":"Ostrer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel F.","family":"Khodursky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9588-5045","authenticated-orcid":false,"given":"James R.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8165-2232","authenticated-orcid":false,"given":"Hiroshi","family":"Hiasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arkady","family":"Khodursky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2018.12.004_bib0001","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1201-9712(03)90043-9","article-title":"Treatment of Salmonella meningitis: two case reports and a review of the literature","volume":"7","author":"Owusu-Ofori","year":"2003","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2018.12.004_bib0002","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11940-018-0490-9","article-title":"Treatment of tuberculous meningitis and its complications in adults","volume":"20","author":"Davis","year":"2018","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/j.ijantimicag.2018.12.004_bib0003","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1442-2042.2010.02500.x","article-title":"Current therapy of acute uncomplicated cystitis","volume":"17","author":"Yamamoto","year":"2010","journal-title":"Int J Urol"},{"key":"10.1016\/j.ijantimicag.2018.12.004_bib0004","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/978-1-4939-7459-7_3","article-title":"DNA topoisomerases as targets for antibacterial agents","volume":"1703","author":"Hiasa","year":"2018","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.ijantimicag.2018.12.004_bib0005","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1021\/cb300648v","article-title":"Drugging topoisomerases: lessons and challenges","volume":"8","author":"Pommier","year":"2013","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.ijantimicag.2018.12.004_bib0006","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00253-011-3557-z","article-title":"Exploiting bacterial DNA gyrase as a drug target: current state and perspectives","volume":"92","author":"Collin","year":"2011","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.ijantimicag.2018.12.004_bib0007","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev-biochem-061809-100002","article-title":"New mechanistic and functional insights into DNA topoisomerases","volume":"82","author":"Chen","year":"2013","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.ijantimicag.2018.12.004_bib0008","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrc2608","article-title":"DNA topoisomerase II and its growing repertoire of biological functions","volume":"9","author":"Nitiss","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ijantimicag.2018.12.004_bib0009","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev.biophys.33.110502.140357","article-title":"Structure, molecular mechanisms, and evolutionary relationships in DNA topoisomerases","volume":"33","author":"Corbett","year":"2004","journal-title":"Annu Rev Biophys Biomol Struct"},{"key":"10.1016\/j.ijantimicag.2018.12.004_bib0010","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1021\/bi5000564","article-title":"Mechanism of quinolone action and resistance","volume":"53","author":"Aldred","year":"2014","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijantimicag.2018.12.004_bib0011","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1128\/AAC.34.6.1271","article-title":"Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli","volume":"34","author":"Yoshida","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.12.004_bib0012","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/nyas.12830","article-title":"Mechanisms of drug resistance: quinolone resistance","volume":"1354","author":"Hooper","year":"2015","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ijantimicag.2018.12.004_bib0013","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/nsmb.1892","article-title":"Structural basis of quinolone inhibition of type IIA topoisomerases and target-mediated resistance","volume":"17","author":"Wohlkonig","year":"2010","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.ijantimicag.2018.12.004_bib0014","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1073\/pnas.1525047113","article-title":"Crystal structure and stability of gyrase\u2013fluoroquinolone cleaved complexes from Mycobacterium tuberculosis","volume":"113","author":"Blower","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijantimicag.2018.12.004_bib0015","doi-asserted-by":"crossref","first-page":"e11338","DOI":"10.1371\/journal.pone.0011338","article-title":"Structural basis of gate-DNA breakage and resealing by type II topoisomerases","volume":"5","author":"Laponogov","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2018.12.004_bib0016","doi-asserted-by":"crossref","first-page":"11801","DOI":"10.1073\/pnas.92.25.11801","article-title":"Topoisomerase IV is a target of quinolones in Escherichia coli","volume":"92","author":"Khodursky","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijantimicag.2018.12.004_bib0017","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1128\/AAC.39.7.1554","article-title":"Analysis of gyrA and grlA mutations in stepwise-selected ciprofloxacin-resistant mutants of Staphylococcus aureus","volume":"39","author":"Ferrero","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"issue":"Database issue","key":"10.1016\/j.ijantimicag.2018.12.004_bib0018","doi-asserted-by":"crossref","first-page":"D581","DOI":"10.1093\/nar\/gkt1099","article-title":"PATRIC, the bacterial bioinformatics database and analysis resource","volume":"42","author":"Wattam","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ijantimicag.2018.12.004_bib0019","doi-asserted-by":"crossref","first-page":"D535","DOI":"10.1093\/nar\/gkw1017","article-title":"Improvements to PATRIC, the all-bacterial bioinformatics database and analysis resource center","volume":"45","author":"Wattam","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ijantimicag.2018.12.004_bib0020","doi-asserted-by":"crossref","first-page":"10915","DOI":"10.1073\/pnas.89.22.10915","article-title":"Amino acid substitution matrices from protein blocks","volume":"89","author":"Henikoff","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijantimicag.2018.12.004_bib0021","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.1128\/AAC.00362-07","article-title":"Determination of the primary target of a quinolone drug and the effect of quinolone resistance-conferring mutations by measuring quinolone sensitivity based on its mode of action","volume":"51","author":"Pfeiffer","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.12.004_bib0022","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1128\/AAC.40.12.2714","article-title":"Differential behaviors of Staphylococcus aureus and Escherichia coli type II DNA topoisomerases","volume":"40","author":"Blanche","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.12.004_bib0023","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1128\/AAC.43.5.1129","article-title":"Streptococcus pneumoniae DNA gyrase and topoisomerase IV: overexpression, purification, and differential inhibition by fluoroquinolones","volume":"43","author":"Pan","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.12.004_bib0024","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1128\/AAC.45.12.3544-3547.2001","article-title":"Target preference of 15 quinolones against Staphylococcus aureus, based on antibacterial activities and target inhibition","volume":"45","author":"Takei","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.12.004_bib0025","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1128\/AAC.41.2.471","article-title":"Targeting of DNA gyrase in Streptococcus pneumoniae by sparfloxacin: selective targeting of gyrase or topoisomerase IV by quinolones","volume":"41","author":"Pan","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.12.004_bib0026","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1128\/AAC.43.2.410","article-title":"Primary targets of fluoroquinolones in Streptococcus pneumoniae","volume":"43","author":"Fukuda","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.12.004_bib0027","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1365-2958.1994.tb01297.x","article-title":"Neisseria gonorrhoeae acquires mutations in analogous regions of gyrA and parC in fluoroquinolone-resistant isolates","volume":"14","author":"Belland","year":"1994","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.ijantimicag.2018.12.004_bib0028","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1128\/AAC.40.10.2321","article-title":"Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae","volume":"40","author":"Pan","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.12.004_bib0029","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF02985800","article-title":"Probability theory: the logic of science","volume":"27","author":"Jaynes","year":"2005","journal-title":"The Mathematical Intelligencer"},{"key":"10.1016\/j.ijantimicag.2018.12.004_bib0030","doi-asserted-by":"crossref","first-page":"4460","DOI":"10.1128\/AAC.48.11.4460-4462.2004","article-title":"Quinolone-resistant Haemophilus influenzae: determination of mutant selection window for ciprofloxacin, garenoxacin, levofloxacin, and moxifloxacin","volume":"48","author":"Li","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.12.004_bib0031","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1128\/AAC.00647-07","article-title":"Contributions of the combined effects of topoisomerase mutations toward fluoroquinolone resistance in Escherichia coli","volume":"51","author":"Morgan-Linnell","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2018.12.004_bib0032","doi-asserted-by":"crossref","first-page":"e65961","DOI":"10.1371\/journal.pone.0065961","article-title":"Novel conserved genotypes correspond to antibiotic resistance phenotypes of E. coli clinical isolates","volume":"8","author":"Swick","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2018.12.004_bib0033","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006805","article-title":"Wicked: the untold story of ciprofloxacin","volume":"14","author":"Conley","year":"2018","journal-title":"PLOS Pathog"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857918303662?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857918303662?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,6]],"date-time":"2019-03-06T00:15:10Z","timestamp":1551831310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857918303662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0924857918303662"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2018.12.004","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of mutational patterns in quinolone resistance-determining regions of GyrA and ParC of clinical isolates","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2018.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}